Now live: Pro — the full 13F research suite for serious investorsSee pricing →
← Tracker

Institutional

DCVC Opportunity Fund II GP, LLC

CIK 0001668343
$13.9M
Reported AUM
2
Positions
Q1 2026
Period
2026-05-15
Filed

The Brief · DCVC Opportunity Fund II GP, LLC · Q1 2026

AI · grounded in 13F

DCVC Opportunity Fund II GP, LLC accumulated IONQ, increasing its share count by 532.6%. The fund added one new position to its portfolio. Total assets under management stood at $13.87M across two positions.

Portfolio · Q1 2026

RXRX$12.1MIONQ$1.7MDL

Top holdings

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1RXRXRecursion Pharmaceuticals, Inc.$2.97-2.62%-46.30%-87.91%$12.1M87.48%HELD
2IONQIonQ, Inc.$31.99-5.58%-13.59%229.73%$1.7M12.52%HELD

Source: SEC EDGAR · accession 0001104659-26-062468. 13F discloses long positions only — shorts, foreign equities, and options are excluded.